|
If you are seeing this message, you may be experiencing temporary network problems. Please wait a few minutes and refresh the page. If the problem persists, you may wish to report it to your local Network Manager.
It is also possible that your web browser is not configured or not able to display style sheets. In this case, although the visual presentation will be degraded, the site should continue to be functional. We recommend using the latest version of Microsoft or Mozilla web browser to help minimise these problems.
Wiley InterScience | ||||||
  BioethicsVolume 20 Issue 1, Pages 37 - 52 Published Online: 21 Dec 2005 Journal compilation © 2010 Blackwell Publishing Ltd Journal of the International Association of Bioethics
Abstract | Full Text: PDF (Size: 125K) | Related Articles | Citation Tracking  NEUROETHICS Copyright © 2006 The Authors. Journal compilation © 2006 Blackwell Publishing Ltd KEYWORDS neuroimaging • psychopharmacology • psychosurgery • deep-brain stimulation • cognitive enhancement • affective enhancement ABSTRACT
Neuroimaging, psychosurgery, deep-brain stimulation, and psychopharmacology hold considerable promise for more accurate prediction and diagnosis and more effective treatment of neurological and psychiatric disorders. Some forms of psychopharmacology may even be able to enhance normal cognitive and affective capacities. But the brain remains the most complex and least understood of all the organs in the human body. Mapping the neural correlates of the mind through brain scans, and altering these correlates through surgery, stimulation, or pharmacological interventions can affect us in both positive and negative ways. We need to carefully weigh the potential benefit against the potential harm of such techniques. This paper examines some of these techniques and explores the emerging ethical issues in clinical neuroscience. | 
|
